Across 26,909 Korean adults in the 2014-2021 national nutrition survey, 23.2% had metabolic dysfunction-associated steatotic liver disease (MASLD). Sleeping four hours or less was tied to 44% higher odds (OR 1.44, 95% CI 1.17-1.78), and sitting eight or more hours daily to 17% higher odds (OR 1.17). Sedentary time barely mediated the sleep-liver relationship: the indirect effect on the hepatic steatosis index was β = -0.0073, against a direct effect of -0.21.
The headline here is the null mediation result, which deserves more attention than the odds ratios. The statistical significance of the indirect pathway reflects sample size, not biology; an effect of 0.007 index points is clinically meaningless, and the authors rightly say so. The sleep-MASLD link fits a larger literature connecting short sleep to insulin resistance, elevated evening cortisol, appetite dysregulation and visceral fat gain, so the association is plausible but largely confirmatory. Important caveats: the data are cross-sectional, so poor liver health could disrupt sleep rather than the reverse; sleep and sedentary time were self-reported; and the hepatic steatosis index is a blood-and-anthropometry formula that includes BMI, so it partly captures obesity rather than liver fat directly. Correlations of -0.06 and 0.02 are tiny. For readers, the practical takeaway is modest: chronic sleep of four hours or less is a flag worth discussing with a doctor, but this study gives no reason to expect that cutting sitting time alone would offset short sleep.